Takea

ASCO 2021 – the exon 20 army lines up behind Rybrevant
EP Vantage
Mon, 06/7/21 - 11:12 am
ASCO 2021
JNJ
Rybrevant
exon 20-insertion NSCLC
Takea
mobocertinib
Dizal Pharmaceutical
Black Diamond Therapeutics